605 related articles for article (PubMed ID: 19136637)
21. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
22. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
Bhalla S; Zhang Z; Patterson N; Gulati A
Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
[TBL] [Abstract][Full Text] [Related]
23. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
Negus SS; Mello NK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
[TBL] [Abstract][Full Text] [Related]
24. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
Endoh T; Tajima A; Izumimoto N; Suzuki T; Saitoh A; Suzuki T; Narita M; Kamei J; Tseng LF; Mizoguchi H; Nagase H
Jpn J Pharmacol; 2001 Mar; 85(3):282-90. PubMed ID: 11325021
[TBL] [Abstract][Full Text] [Related]
25. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
Kest B; McLemore G; Kao B; Inturrisi CE
J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
[TBL] [Abstract][Full Text] [Related]
26. The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Zamarripa CA; Pareek T; Schrock HM; Prisinzano TE; Blough BE; Sufka KJ; Freeman KB
Psychopharmacology (Berl); 2021 Dec; 238(12):3463-3476. PubMed ID: 34430992
[TBL] [Abstract][Full Text] [Related]
27. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
28. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
29. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Bhargava HN; Cao YJ; Zhao GM
Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
[TBL] [Abstract][Full Text] [Related]
30. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
31. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
32. Dietary modulation of mu and kappa opioid receptor-mediated analgesia.
Kanarek RB; Przypek J; D'Anci KE; Marks-Kaufman R
Pharmacol Biochem Behav; 1997 Sep; 58(1):43-9. PubMed ID: 9264068
[TBL] [Abstract][Full Text] [Related]
33. Novel selective κ agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion.
Wei YY; Ma Y; Yao SY; Kong LH; Liu X; Chai JR; Chen J; Li W; Wang YJ; Shao LM; Liu JG
Acta Pharmacol Sin; 2022 Jun; 43(6):1372-1382. PubMed ID: 34493813
[TBL] [Abstract][Full Text] [Related]
34. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H
Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
36. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
[TBL] [Abstract][Full Text] [Related]
37. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.
Danzebrink RM; Green SA; Gebhart GF
Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice.
Ito S; Mori T; Sawaguchi T
Behav Pharmacol; 2006 Dec; 17(8):691-701. PubMed ID: 17110795
[TBL] [Abstract][Full Text] [Related]
39. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
[TBL] [Abstract][Full Text] [Related]
40. Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist.
Endoh T; Matsuura H; Tajima A; Izumimoto N; Tajima C; Suzuki T; Saitoh A; Suzuki T; Narita M; Tseng L; Nagase H
Life Sci; 1999; 65(16):1685-94. PubMed ID: 10573186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]